Showing results (111-120 of 163) with videos related to
Sort By:
Pageof 17
Archiv Der Pharmazie|September 29, 2025
New 1,3,4-Thiadiazole-Based Dual B-Raf/VEGFR-2 Inhibitors With Potential Anti-Breast Activity: Design, Synthesis, In Vitro and In Silico EvaluationsWalid E Elgammal, Hazem Elkady, Hazem A Mahdy, et al.Archiv Der Pharmazie|July 1, 2025
Development of New Thiadiazole Derivatives as VEGFR-2 Inhibitors With Anticancer and Proapoptotic ActivitiesHazem Elkady, Walid E Elgammal, Mohamed M Khalifa, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|July 23, 2025
Integrated computational and biological evaluations of newly synthesized thiadiazole-based VEGFR-2 inhibitors with targeted anti-breast cancer activityBshra A Alsfouk, Walid E Elgammal, Hazem Elkady, et al.Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|November 29, 2023
Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2Ibrahim H Eissa, Reda G Yousef, Mostafa A Asmaey, et al.Plants (Basel, Switzerland)|August 12, 2022
Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-O-(6″-O-acetyl)-Glucoside from Calligonum tetrapterumYerlan M Suleimen, Rani A Jose, Gulnur K Mamytbekova, et al.Current Cancer Drug Targets|October 2, 2025
Integrated Computational and Experimental Discovery of a Promising Xanthine Derivative with Anticancer Potential Targeting EGFREslam B Elkaeed, Reda G Yousef, Hazem Elkady, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|July 8, 2022
Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studiesMohammed S Taghour, Hazem Elkady, Wagdy M Eldehna, et al.Molecules (Basel, Switzerland)|March 10, 2022
Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main ProteaseYerlan M Suleimen, Rani A Jose, Raigul N Suleimen, et al.Scientific Reports|July 27, 2022
Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activityWagdy M Eldehna, Mahmoud A El Hassab, Zainab M Elsayed, et al.Computational Biology and Chemistry|September 27, 2024
Anti-proliferative 2,3-dihydro-1,3,4-thiadiazoles targeting VEGFR-2: Design, synthesis, in vitro, and in silico studiesHazem Elkady, Walid E Elgammal, Hazem A Mahdy, et al.Pageof 17